Sutro Biopharma's low P/S ratio indicates expected growth no...

Sutro Biopharma's low P/S ratio indicates expected growth not meeting industry standards. This leads investors to anticipate limited future growth, consequently paying less for the stock. Enhanced fortunes could increase the P/S ratio.